Tag: Tariff
F&P reports ‘strong’ first half
August 21, 2025HME News Staff
AUCKLAND, New Zealand – Fisher & Paykel Healthcare has provided guidance for the first half of the 2026 financial year, which ends September 2025.
At July 31 exchange rates, guidance assumptions for the first half of the 2026 financial year include a continuation of the current trading environment and result in revenue of approximately $1.075 billion and net profit after tax of approximately $200 million. This would equate to approximately 13% growth in reported operating...
Tariffs update: Manufacturers hold steady
May 28, 2025Liz Beaulieu, Editor
YARMOUTH, Maine – HME manufacturers say they are committed to trying to avoid price increases as they keep a watchful eye on trade negotiations and work through any changes in tariffs.
Manufacturers contacted by HME News in April and May, including React Health, said they have largely avoided increasing their prices so far, due in part to their ability to confirm tariff exemptions for their products.
“Increasing prices, adding surcharges and nickel and diming customers...
Industry fans out across Capitol Hill
May 15, 2025HME News Staff
WASHINGTON - More than 120 HME stakeholders met with members of Congress and staff as part of the AAHomecare Washington Legislative Conference on May 13 to discuss policy priorities, including Medicare reimbursement, proposed changes to NIV coverage, patient access to upgraded wheelchairs, Medicare Advantage and proposed tariffs. AAHomecare says the meetings come at a critical time for building support for H.R. 2005 and paving the way for a Senate companion bill to reestablish the 75-25 blended reimbursement...
NCPA warns of further strain on indie pharmacies
May 12, 2025HME News Staff
ALEXANDRIA, Va. - The National Community Pharmacists Association, in recent comments to the Department of Commerce, is urging the Trump administration to ensure that any tariffs on the pharmaceutical sector are carefully tailored to avoid further strain on patients and independently owned community and long-term care pharmacies.
The association expressed specific concerns that tariffs could trigger shortages in the near term and force independent pharmacies to absorb higher costs.
“Pharmacies...
AAH, VGM seek tariff info
May 12, 2025HME News Staff
WASHINGTON – AAHomecare and VGM Group are polling DMEPOS manufacturers and vendor partners about tariffs. “We invite manufacturers and vendor partners to participate in this brief, confidential survey to help us assess the impact of these tariffs on the production and distribution of DME and medical supplies,” the associations state. “Your input will directly support our advocacy efforts to secure tariff exemptions and ensure uninterrupted access to essential healthcare products...
In brief: Quipt & InfuSystem report earnings, NCPA warns of strain, Belluscura reviews strategy
May 12, 2025HME News Staff
CINCINNATI – Quipt Home Medical has reported revenue of $57.4 million for the second quarter of 2025 compared to $61.3 million for the same period last year, a 6% decrease.
The company says revenue was impacted by ongoing headwinds from the withdrawal of Medicare Advantage members, following a capitated agreement that went to other providers in the industry, and a disposable supply contract that was not renewed.
On a positive note, the company says it saw improved momentum...
Philips works to keep tariff impact in check
May 9, 2025Liz Beaulieu, Editor
AMSTERDAM – Philips expects a net tariff impact of EUR 250 million to EUR 300 million, even as it accelerates substantial mitigation actions, company officials said during a recent conference call to discuss first quarter financial results.
President and CEO Roy Jakobs explained that Philips has taken proactive steps for the past several years to build a more resilient supply chain, including diversifying and regionalizing key operations, especially in China, well ahead of the tariffs...
Cardinal Health juggles business, supply demands in costlier environment
May 9, 2025Liz Beaulieu, Editor
DUBLIN, Ohio – Cardinal Health anticipates roughly $200 million to $300 million in tariff-related costs in fiscal year 2026 before further mitigations, affecting almost exclusively its Global Medical Products and Distribution segment.
The company says its four other segments will be largely unaffected by the tariffs implemented to date by U.S. President Donald Trump.
“Within GMPD, we have been proactive and aggressive in implementing mitigation actions to reduce the...
Tariffs, tech, payer alignment top of mind at Option Care
May 2, 2025Theresa Flaherty, Managing Editor
BANNOCKBURN, Ill. – Option Care neither manufactures nor directly imports products that may be subject to tariffs, but the company is still performing its due diligence as it keeps an eye on the constantly evolving landscape.
As of May, there is a 125% tariff on products imported from China and a 10% general tariff on imported products from other countries.
“We’ve had a team that has been working to do a comprehensive review of all of our country of origin for...
Trump’s tariffs: Resmed ‘well-positioned’ with exemptions, CEO says
April 25, 2025Liz Beaulieu, Editor
SAN DIEGO – Resmed says that U.S. Customs and Border Protection has confirmed that its devices will continue to be exempt from tariffs and, therefore, the company does not expect a material impact on its financial results from any new tariffs.
As of April, the ever-changing tariff landscape included a 10% general tariff on imported products and a 145% tariff on imported products from China.
“I can report that because of the fact that our products are used to treat patients...